Skip to main content
2023 CLA Conference

Role of NRAS Q61R in the Pathogenesis of Kaposiform Lymphangiomatosis

Unveiling Hope: The NRAS Q61R Mutation in KLA

In this captivating video, Tim Le Cras, PhD and PhD Candidates: Sara Alharbi & C. Griffin McDaniel take you on a journey through the groundbreaking research that uncovers the critical link between Kaposiform Lymphangiomatosis (KLA) and the NRAS Q61R mutation. 

Segment 1: Deciphering KLA

  • Introduction to the complexities of KLA, a rare disease with multifocal lesions.
  • The pressing need for effective treatments for KLA patients.

Segment 2: The NRAS Q61R Mutation

  • Delving into the NRAS mutation and its prevalence among KLA patients.
  • Exploring how the NRAS mutation impacts KLA's development.

Segment 3: Research Breakthrough

  • Understanding how this discovery is reshaping the future for KLA patients.
  • The pivotal role of the NRAS mutation in KLA diagnosis and treatment.

Segment 4: Implications for Patients

  • Discover how KLA patients stand to gain from this groundbreaking research.
  • The potential for personalized medicine and brighter prognoses.

Segment 5: Clinical Trials and Hope

  • A glimpse into the promising clinical trials and innovative therapies on the horizon.
  • The vital role of advocacy and support for KLA patients and their families.